Started from NCKU, Riche Biotech Inc. develops ATOM NAAT technology that provide a novel solution to manipulate DNA directly at molecular level, and can achieve a point-of-care qPCR based rapid diagnostic, making the most reliable diagnostic unit available in the frontline.
